Cargando…
Performance of next-generation sequencing on small tumor specimens and/or low tumor content samples using a commercially available platform
BACKGROUND: Next generation sequencing tests (NGS) are usually performed on relatively small core biopsy or fine needle aspiration (FNA) samples. Data is limited on what amount of tumor by volume or minimum number of FNA passes are needed to yield sufficient material for running NGS. We sought to id...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922576/ https://www.ncbi.nlm.nih.gov/pubmed/29702695 http://dx.doi.org/10.1371/journal.pone.0196556 |